Indoor Air Quality Asthma Study: The Effect of Indoor Air Quality and Mitigation of Same on Persistent Asthma

NCT05843045 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2024-01-08

No results posted yet for this study

Summary

The primary objective is to determine whether continuous sensing, control and mitigation of home indoor air quality influences the frequency of asthma related symptoms, as measured by Serum IgE, Spirometry with exhaled Nitric Oxide, missed school and workdays, need for pharmacologic intervention (albuterol, oral steroids), frequency of sick visits to pulmonologist or primary care provider (PCP), urgent care / emergency department visits, and hospitalizations

Conditions

  • Persistent Asthma

Interventions

DEVICE

Indoor Air Quality Mitigation

Mitigation of indoor air quality with use of smart thermostat, smart bath fan control, and high quality furnace filters

Sponsors & Collaborators

  • Cairify LLC

    collaborator UNKNOWN
  • Copeland LP

    collaborator UNKNOWN
  • Dayton Children's Hospital

    lead OTHER

Principal Investigators

  • Daniel A. Evans, MD · Dayton Children's Hospital

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
5 Years
Max Age
15 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-08-18
Primary Completion
2025-08-31
Completion
2026-01-12

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05843045 on ClinicalTrials.gov